Clinical Trials Browser

OTHER × Salivary Gland Neoplasms × Sorafenib × Clear all

NCT01703455 2023-10-19

Activity of Sorafenib in Salivary Gland Cancer

Phase 2 Completed

Salivary Gland Neoplasms

NCT02035527 2018-05-24

Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Salivary Gland Neoplasms, Tongue Neoplasms